US stocks end flat to softer as Fed effect fizzles out
US stocks closed Friday flat to softer as mid-week euphoria over a rate hike fizzled out, and so did the so-called Trump rally
Company
Amgen Inc
NASDAQ:AMGN
Amgen Inc is an independent biotechnology medicines company that discovers, develops, manufactures and markets medicines for grievous illnesses. It focuses on human therapeutics and concentrates on medicines based on advances in cellular and molecular biology.
45 stories · page 2 of 3
US stocks give back early gains to close lower on healthcare scare
US equities fell on Thursday, as initially buoyant stocks came off on the back of falls by utilities and a budgetary shock for the healthcare sector
Amgen up after judge rules rivals must pull a competing cholesterol drug off the market
District Judge Sue Robinson in Delaware announced a ban on Regeneron and Sanofi from selling their cholesterol drug, Praluent on the grounds of patent infringement.
US stocks clinch record highs, Dow skids (just) shy of 20,000 after jobs report
US stocks clinched fresh record highs on Friday, with the Dow coming within a hair’s breadth of 20,000 – which can only have been helped by Goldman Sach’s shares driving 1.5% higher
Radius Health shares rise 10% on continued bid rumours
Radius Health Inc shares were 10% higher on Friday on continued bid rumours
Unilife licensing gives shares a boost
Unilife announces a strategic collaboration with Amgen
Radius soars as Amgen sees mixed results for osteoporosis drug
Amgen's new osteoporosis treatment may not be as effective as a rival drug being developed by Radius.
Amgen pleased with Phase III anemia trial results
Anemia is a condition in which there is a deficiency of red cells or of haemoglobin in the blood, resulting in tiredness and a lack of energy.
Unilife soars on licensing deal with Amgen
Other interested parties have been told they are out of luck after Unilife decided on Amgen as its partner
Markets off to worst start to a year since 2001
Marine shipping companies got it in the neck but energy companies bucked the trend
Wall Street shares forge ahead after Yellen comments
At the time of writing, the benchmark Dow Jones was up 170 points to 16,371, the Nasdaq gained 32 to 4,765 and the S&P500 added 14 to 1,946.
Archive
Wall Street shares start higher as traders get a break from China
As expected, US shares opened positively as traders welcomed the fact China markets were closed...
AstraZeneca licenses psoriasis rights to Valeant
After Amgen, the originator of the skin condition treatment, abandoned brodalumab, Astra has called on the Canadian dermatology specialist to develop the drug.
Wall Street fell as weak earnings nudge down energy producers; Exxon, Chevron drop
Wall Street was trading lower today as a drop in energy companies' stocks overpowered expectations the U.S. Federal Reserve may delay an interest-rate hike this year following weak wage data. The S&P 500 (INDEXSP:.INX) fell 0.2 percent
Wall Street drops amid Greece debt saga; energy shares slump
U.S. stocks declined as energy stocks dropped with oil and financial shares fell from a seven-year high and as investors eyed the Greece debt saga. The S&P 500 (INDEXSP:.INX) fell 0.4 percent to 2,112.21 at 3:38 p.m. in New York. The 30